Home > Financial Ratios > INDOCO REMEDIES

INDOCO REMEDIES
EV/Core EBITDA

    Back to All Ratios
INDOCO REMEDIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for INDOCO REMEDIES
Please provide your vote to see the results

INDOCO REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 29.7314.3411.4411.2112.77

What is the latest EV/Core EBITDA ratio of INDOCO REMEDIES ?

The latest EV/Core EBITDA ratio of INDOCO REMEDIES is 29.73 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202529.73
Mar202414.34
Mar202311.44
Mar202211.21
Mar202112.77

How is EV/Core EBITDA of INDOCO REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2025 29.73
107.32
Mar2024 14.34
25.35
Mar2023 11.44
2.05
Mar2022 11.21
-12.22
Mar2021 12.77 -

Other Financial Ratios of INDOCO REMEDIES


Compare EV/Core EBITDA ratio of peers of INDOCO REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
INDOCO REMEDIES ₹2,804.3 Cr 9.9% 6.7% -21.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹386,497.0 Cr 1.1% -1.9% -14.1% Stock Analytics
DIVIS LABORATORIES ₹161,787.0 Cr 1.1% -0.6% 10.4% Stock Analytics
CIPLA ₹125,870.0 Cr -0.4% -0.4% -6.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,591.0 Cr -1.7% -2.5% 2.1% Stock Analytics
DR REDDYS LABORATORIES ₹109,380.0 Cr 0.5% 4.1% -2.7% Stock Analytics


INDOCO REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
INDOCO REMEDIES

9.9%

6.7%

-21.3%

SENSEX

1.6%

2.3%

1.1%


You may also like the below Video Courses